Search

Vaxcyte Inc

Lezárt

SzektorEgészségügy

60.85 -0.56

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

59.6

Maximum

61.9

Fő mutatók

By Trading Economics

Bevétel

-284M

-605M

Egy részvényre jutó nyereség

-1.97

Munkavállalók

507

EBITDA

22M

-292M

Ajánlások

By TipRanks

Ajánlások

Erős vétel

12 hónapos előrejelzés

+85.66% upside

Osztalékok

By Acuity

Következő eredményjelentés

2026. nov. 2.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

1.3B

9B

Előző nyitás

61.41

Előző zárás

60.85

Hangulat hírek alapján

By Acuity

50%

50%

149 / 339 Rangsor szerint Healthcare

Vaxcyte Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. szept. 3. 20:14 UTC

News

Vaxcyte shares are lower in after-market hours following leadership appointments and narrowed guidance for VAX-31 topline data, now expected by October 2026.

2026. szept. 2. 20:08 UTC

Vaxcyte Inc is gaining today, driven by strong performance in the Biotechnology sub-sector, despite earlier pulling back from a session high.

2026. szept. 1. 20:09 UTC

Vaxcyte Inc shares are lower today, influenced by a broad market decline amid rising oil prices and increasing Treasury yields. No specific company news was identified.

2026. aug. 31. 19:16 UTC

Vaxcyte Inc is trading higher since Friday's close, reflecting a positive performance backdrop. Shares remain above their 20-day moving average.

2026. aug. 28. 20:07 UTC

Vaxcyte Inc shares are lower amid a broader market downturn. Rising U.S. Treasury yields and inflation concerns contribute to the decline in equity prices.

2026. aug. 25. 20:07 UTC

Vaxcyte Inc. shares are lower today, having peaked earlier before drifting downwards. The broader market sees a drop in oil prices and Treasury yields.

2026. aug. 24. 19:46 UTC

Vaxcyte Inc's shares are lower amid rising oil prices and geopolitical tensions. No specific company news was identified to explain the decline.

2026. aug. 21. 21:01 UTC

Vaxcyte Inc is trading higher in after-market hours, maintaining a notable increase since Friday's close, amid positive market sentiment.

2026. aug. 20. 23:46 UTC

Vaxcyte Inc shares are lower in after-market hours, with no specific news identified. Broader market declines may be affecting investor sentiment in biotechnology.

2026. aug. 19. 20:02 UTC

Correlated Moves

Vaxcyte Inc. shares are higher during Wednesday's session, continuing a positive trend with strong investor interest. The stock aligns with gains in the biotechnology sector.

2026. aug. 14. 20:06 UTC

Vaxcyte Inc's shares are lower today, breaking a trend of higher closes. This decline aligns with weaker-than-expected U.S. retail sales data for July.

2026. aug. 12. 19:46 UTC

Vaxcyte Inc shares are higher today, supported by broader market gains following positive sentiment from the recent inflation report. The stock remains above its 20-day moving average.

2026. aug. 11. 23:11 UTC

Vaxcyte Inc shares are higher in after-market trading, reflecting positive momentum despite no specific news driving the price action.

2026. aug. 10. 19:56 UTC

Vaxcyte Inc shares are higher, continuing gains since Friday's close, reaching a peak earlier in the session. No specific news was identified for the move.

2026. aug. 7. 21:01 UTC

Vaxcyte Inc shares are lower in after-market hours, continuing a weak trading session without any specific news to explain the decline.

2026. aug. 6. 20:03 UTC

News

Vaxcyte reports a net loss of $284.3 million for Q2. Shares are trading higher as the company anticipates key Phase 3 trial data in 2027.

2026. aug. 5. 19:16 UTC

Vaxcyte Inc. shares are higher today, aligning with broader market trends, despite no specific news identified. The stock remains near its one-month range low.

2026. aug. 4. 20:21 UTC

Vaxcyte Inc. shares are lower in after-market trading, remaining flat since Tuesday's close and positioned below its 20-day moving average.

2026. aug. 3. 19:46 UTC

Vaxcyte Inc's shares are lower today, continuing a decline since Friday. The stock is trading near the lower end of its one-month range.

2026. júl. 31. 19:56 UTC

Correlated Moves

Shares lower amid broader sector sentiment; SPDR S&P Biotech ETF declines.

2026. júl. 30. 18:52 UTC

Vaxcyte Inc's shares are higher today amid strong buying activity, reaching an intraday high but remain below the 20-day moving average.

2026. júl. 29. 18:23 UTC

Vaxcyte Inc is lower in Wednesday's session, breaking a trend of higher daily closes. No specific news was identified to explain the decline.

2026. júl. 28. 18:46 UTC

Vaxcyte Inc. shares are trading lower amid broader market trends and volatility, remaining below the 20-day moving average as bond yields decline.

2026. júl. 27. 19:46 UTC

Vaxcyte Inc shares are trading higher today, despite earlier declines and without specific company news. Broader market volatility is influenced by falling crude oil prices.

2026. júl. 23. 19:16 UTC

Vaxcyte Inc shares are lower today amid a broader decline in tech stocks following earnings reports from Alphabet and Tesla. No specific news was identified.

2026. júl. 21. 18:26 UTC

Vaxcyte Inc is trading higher today, continuing its advance since Monday's close. This movement occurs despite concerns over rising treasury yields and geopolitical tensions.

Társak összehasonlítása

Árváltozás

Vaxcyte Inc Előrejelzés

Célár

By TipRanks

85.66% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 114.33 USD  85.66%

Magas 163 USD

Alacsony 75 USD

6 Wall Street elemző 12 hónapos célárain alapulva a(z)Vaxcyte Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Erős vétel

6 ratings

6

Vétel

0

Tartás

0

Eladás

Hangulat

By Acuity

149 / 339 Rangsor szerint Egészségügy

Hangulat hírek alapján

Neutral

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Vaxcyte Inc

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
help-icon Live chat